Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M138Revenue $M1.8Net Margin (%)-2,037.7Altman Z-Score3.1
Enterprise Value $M39.8EPS $-1.0Operating Margin %-1,949.9Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-2,037.7Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio10.4Cash flow > EarningsN
Price/Sales68.95-y EBITDA Growth Rate %--Current Ratio10.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-38.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-48.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-11-17Buy10,000$8.25-32.24view
Fortune JamesCOO 2015-09-15Sell9,470$17.16-67.42view
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-09-14Buy15,000$16.5-66.12view
Versant Venture Capital III, L10% Owner 2015-06-15Sell320,000$22-74.59view
Warden Charles MDirector, 10% Owner 2015-06-15Sell320,000$22-74.59view
SVLSF IV, LLC10% Owner 2015-06-10Sell1,119,000$22-74.59view
Versant Venture Capital III, L10% Owner 2015-06-10Sell427,000$22-74.59view
Warden Charles MDirector, 10% Owner 2015-06-10Sell427,000$22-74.59view
Polaris Venture Management Co.10% Owner 2015-02-02Sell500,000$29.5-81.05view
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$13-57view

Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    Ocular TherapeutixTM Strengthens Executive Management Team with the Appointment of Highly Regarded... Jan 11 2016
    Ocular TherapeutixTM Strengthens Executive Management Team with the Appointment of Highly Regarded... Jan 11 2016
    Ocular Therapeutix, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 23 2015
    Ocular Therapeutix (OCUL) Shares March Higher, Can It Continue? Dec 21 2015
    4 Biotech Stocks Under $10 Poised for Big Breakouts Dec 18 2015
    New Information Reveals Opportunity in Volatility - Free Research on Rocket Fuel, Ocular... Dec 16 2015
    Ocular Therapeutix, Inc. (Nasdaq: OCUL) to Ring The Nasdaq Stock Market Opening Bell Dec 14 2015
    Ocular Therapeutix™ Announces Encouraging Top-Line Results from Exploratory Phase 2 Trial for... Dec 14 2015
    Ocular Therapeutix™ Announces Encouraging Top-Line Results from Exploratory Phase 2 Trial for... Dec 14 2015
    16 Stocks Moving In Friday's After-Hours Session Dec 11 2015
    Ocular Therapeutix, Inc. (Nasdaq: OCUL) to Ring the Nasdaq Stock Market Opening Bell Dec 11 2015
    Ocular Therapeutix, Inc. (Nasdaq: OCUL) to Ring the Nasdaq Stock Market Opening Bell Dec 11 2015
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Dec 09 2015
    Ocular Therapeutix™ Announces FDA Acceptance of NDA Filing for DEXTENZA™ for the Treatment of... Dec 09 2015
    Ocular Therapeutix™ Announces FDA Acceptance of NDA Filing for DEXTENZA™ for the Treatment of... Dec 09 2015
    OCULAR THERAPEUTIX, INC Financials Dec 08 2015
    Is Pfenex Inc (PFNX) Going to Burn These Hedge Funds? Nov 27 2015
    Ocular Begins Second Phase III Allergic Conjunctivitis Study Nov 26 2015
    Ocular Therapeutix™ to Present at the Piper Jaffray 27th Annual Healthcare Conference Nov 24 2015
    Ocular Therapeutix™ to Present at the Piper Jaffray 27th Annual Healthcare Conference Nov 24 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK